However, under ACE inhibition, minimal change disease patients no longer had a significantly different uEGF/uCreat compared to the “FSGS/IgAN, GN” group, due to a pronounced increase in uEGF/uCreat in the latter biopsy group. The gene discussed is ACE; the disease is ganglioneuroma.